Intraretinal Hyperreflective Foci

Intraretinal hyperreflective foci (IHRF) are defined as small, discrete hyperreflective dots in anatomical continuity with the neurosensory retina, typically measuring less than 30–40 μm in diameter. Their reflectivity is variable but often comparable to the inner retinal layers or the retinal nerve fiber layer (RNFL). A key characteristic that distinguishes IHRF from larger lipid exudates or calcified deposits is their small size and the absence of significant posterior shadowing.

The sources highlight that these “dots” are not a single entity but a spectrum of biological processes, including microglial activation, RPE migration, and lipid deposition. To better detect and define these processes, various OCT modalities are utilized:

Core OCT Characteristics and Subtypes

The sources suggest a standardized classification based on specific imaging features to help identify the biological origin of these foci:

• Inflammatory IHRF (I-IHRF): These present as scattered, punctate hyperreflective dots, primarily in the inner retinal layers (such as the INL and IPL), representing activated microglia or macrophages.
• Pigmentary IHRF (P-IHRF): Arising from migrating RPE cells, these are highly hyperreflective due to melanin content and are typically found in the outer retinal layers. They often migrate from the outer to the inner retina as diseases like AMD progress.
• Exudative IHRF (E-IHRF): These reflect extravasated lipoproteins and are often clustered around edema cavities.
• Vascular IHRF (V-IHRF): These represent cross-sections of retinal vessels or vascular abnormalities.

Advanced Detection and Imaging Technologies

While Spectral-Domain OCT (SD-OCT) is considered the gold standard for detection due to its high axial resolution (3–7 μm), several other technologies provide deeper insights:

• High-Resolution OCT (HR-OCT): Provides axial resolution of 3 μm or less, reducing the risk of underestimating smaller foci that standard SD-OCT might miss.
• Polarization-Sensitive OCT (PS-OCT): This is critical for identifying pigmentary IHRF. It detects the depolarization signal associated with melanin-containing RPE cells, allowing researchers to specifically track RPE migration in AMD with greater specificity than conventional imaging.
• En Face OCT: This technique offers a topographic map of IHRF distribution. It is particularly useful for analyzing migration patterns—for instance, observing IHRF moving from inner to outer layers in diabetic retinopathy, or the inverse pattern in AMD.
• OCT Angiography (OCTA): OCTA is essential for differentiating vascular from non-vascular lesions. It can identify flow signals (decorrelation) that distinguish early neovascular complexes, like Type 3 macular neovascularization, from non-vascular inflammatory debris or pigment aggregates.
• AI and Deep Learning: Automated algorithms have transformed IHRF analysis from subjective manual counting to objective, reproducible quantification. These systems can track the evolution of IHRF over time, identifying subtle patterns of progression that may be missed by human observers.

Comparative Differences Across Diseases

Detection methods have also revealed that IHRF characteristics vary by disease context. For example, IHRF in diabetic retinopathy tend to be larger and more numerous but less reflective than those in AMD, which are typically smaller, fewer, and more hyperreflective. This underscores the importance of using multimodal imaging—combining structural OCT with OCTA and PS-OCT—to accurately define the nature of these biomarkers.

The sources define intraretinal hyperreflective foci (IHRF) as small, discrete, punctate hyperreflective dots observed on optical coherence tomography (OCT) within the neurosensory retina. These structures typically measure less than 30–40 μm in diameter and exhibit reflectivity comparable to the inner retinal layers. While various terms like “hyperreflective dots” or “spots” have been used interchangeably, the sources adopt “intraretinal hyperreflective foci” as a comprehensive, unified terminology to harmonize clinical descriptions across various retinal diseases.

Detection of these foci relies on a variety of imaging modalities, with Spectral-domain OCT (SD-OCT) serving as the current gold standard. The following modalities are discussed in the context of their specific contributions to IHRF detection and characterization:

Primary OCT Modalities

• Spectral-Domain OCT (SD-OCT): Its superior axial resolution (3–7 μm) allows for the visualization of IHRF that are often undetectable through conventional fundus photography or clinical biomicroscopy.
• Swept-Source OCT (SS-OCT): Utilizing longer wavelengths (~1050 nm), this modality offers enhanced penetration through media opacities and is particularly effective at visualizing deeper or larger foci near the choroid or subretinal space.
• High-Resolution OCT (HR-OCT): This evolution provides axial resolutions of 3 μm or less, enabling even more precise visualization and reducing the risk of underestimation associated with standard SD-OCT.
• Enhanced Depth Imaging (EDI-OCT): While it does not directly enhance IHRF detection, it provides critical information about the choroidal compartment, aiding in the differential diagnosis of the underlying disease.

Specialized and Advanced Imaging

• Polarization-Sensitive OCT (PS-OCT): This technology identifies the tissue’s birefringent properties, allowing clinicians to differentiate migrated RPE cells (which exhibit depolarization due to melanin) from other inflammatory cellular infiltrates.
• En Face OCT: This provides topographic mapping of IHRF distribution patterns across specific retinal layers. It is used to understand migration patterns, such as the inward movement seen in AMD or the outward movement in diabetic retinopathy.
• OCT Angiography (OCTA): Crucial for differentiating vascular from non-vascular lesions, OCTA can identify decorrelation signals that distinguish early neovascular complexes (like Type 3 MNV) from non-vascular inflammatory aggregates or pigment.
• Adaptive Optics Scanning Laser Ophthalmoscopy (AOSLO): This research tool provides cellular-level resolution, enabling direct visualization of individual photoreceptors and RPE cells to better understand IHRF composition.

Automated Detection and Multimodal Context

The sources emphasize that contemporary assessment increasingly integrates Artificial Intelligence (AI) and Deep Learning (DL) for objective, reproducible quantification and tracking of IHRF over time, which may reveal subtle patterns not apparent to human observers. Furthermore, while structural OCT is the only modality that directly detects IHRF, multimodal integration with tools like Fundus Autofluorescence (FAF) and Near-Infrared Reflectance (NIR) is essential to provide the necessary biological context regarding RPE stress and pigmentary alterations.

The pathophysiology of intraretinal hyperreflective foci (IHRF) is fundamentally heterogeneous, representing a diverse spectrum of biological processes rather than a single entity. Their appearance on OCT reflects distinct pathogenic mechanisms—including inflammatory cell recruitment, lipid or proteinaceous material deposition, and degenerative tissue remodeling—that vary significantly depending on the underlying disease.

To reconcile these various origins, the sources propose a standardized, pathophysiology-oriented classification into four primary categories:

1. Inflammatory IHRF (I-IHRF)

• Biological Origin: These represent clusters of activated microglia, macrophages, or other inflammatory cellular infiltrates.
• Mechanism: In diseases like diabetic retinopathy (DR), resting microglia (normally located in the inner retina) become activated and migrate toward the outer retinal layers in response to injury or stress. This process is often linked to a pro-inflammatory microenvironment characterized by elevated cytokines such as IL-6, IL-8, and MCP-1.
• Clinical Context: They serve as biomarkers of neuroinflammation and immune activation, particularly in vascular and inflammatory retinopathies.

2. Pigmentary IHRF (P-IHRF)

• Biological Origin: These arise from migrating or degenerating retinal pigment epithelium (RPE) cells that contain melanin.
• Mechanism: In age-related macular degeneration (AMD), RPE cells can undergo an epithelial–mesenchymal transition (EMT), where they lose their normal function, gain immune-like properties, and migrate anteriorly into the neurosensory retina. This migration is often triggered by RPE destabilization, oxidative stress, or chronic ischemia caused by a failure of choroidal support (particularly at the apex of large drusen).
• Clinical Context: Their presence is a critical indicator of RPE stress and a strong predictor of progression toward geographic atrophy or neovascularization.

3. Exudative IHRF (E-IHRF)

• Biological Origin: These correspond to extravasated lipoproteins, proteinaceous material, or lipid-laden macrophages (often termed “gitter cells”).
• Mechanism: Their formation is driven by the breakdown of the blood–retinal barrier (BRB), leading to the leakage and accumulation of macromolecules within the retinal parenchyma. In conditions like diabetic macular edema (DME) and retinal vein occlusion (RVO), they are often found clustered around edema cavities or cystoid spaces.
• Clinical Context: They serve as markers of the severity of vascular leakage and macular edema.

4. Vascular IHRF (V-IHRF)

• Biological Origin: These represent cross-sections of retinal vessels or vascular abnormalities, such as early angiogenic sprouts.
• Mechanism: In Type 3 macular neovascularization (MNV), these foci may reflect nascent intraretinal neovascular buds sprouting from the deep capillary plexus (DCP) and advancing toward the sub-RPE space.
• Clinical Context: They are early biomarkers of intraretinal angiogenesis and vascular remodeling.

Dynamic Behavior and Migration

A key pathophysiological feature of IHRF is their dynamic behavior over time. Longitudinal studies have identified distinct migration patterns that encode information about disease progression:

• In AMD: Foci typically migrate from the outer retina toward the inner layers, marking the trajectory of degenerating RPE cells.
• In DR: Foci often demonstrate an inverse movement from the inner toward the outer retinal layers, reflecting the activation and migration of microglial cells.

Genetic and Molecular Modulation

Pathophysiology is further influenced by genetic and systemic factors. Genetic polymorphisms related to complement activation (CFH), lipid metabolism (APOE), and extracellular matrix remodeling (ARMS2/HTRA1) have been linked to the development of IHRF in AMD. Systemically, chronic low-grade inflammation—indicated by ratios like the platelet–lymphocyte ratio—may “prime” retinal immune cells, contributing to IHRF formation in treatment-naïve DME.

The clinical implications of intraretinal hyperreflective foci (IHRF) have evolved from their initial description as incidental “imaging noise” to their current status as versatile, quantifiable biomarkers for diagnosis, risk stratification, and treatment monitoring. Across various retinal diseases, the presence, distribution, and temporal evolution of these foci provide critical insights into disease activity, structural progression, and functional prognosis.

The following sections detail the clinical implications of IHRF across specific disease states as described in the sources:

Age-Related Macular Degeneration (AMD)

In AMD, IHRF are considered active indicators of RPE destabilization and inflammatory engagement rather than static deposits.

• Progression to Atrophy: In intermediate AMD, IHRF clustering over drusen or at the apex of drusenoid pigment epithelial detachments (dPED) is a strong predictor of progression toward geographic atrophy (GA). In late-stage GA, the presence of IHRF in the junctional zone correlates with faster lesion expansion.
• Type 3 Macular Neovascularization (MNV): IHRF are recognized as the earliest morphological expression of Type 3 MNV, often appearing as “nascent” intraretinal angiogenic sprouts before exudative conversion occurs.
• Treatment Response: Higher baseline IHRF counts—especially in the inner retinal layers—are associated with poorer visual outcomes following anti-VEGF therapy.

Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)

IHRF in diabetic eyes serve as primary structural markers for neuroinflammation and microglial activation.

• Predicting Functional Loss: The migration of IHRF from the inner to the outer retinal layers is linked to photoreceptor damage and decreased visual acuity.
• Treatment Guidance: The presence of a high IHRF burden signals an inflammatory phenotype of DME. Studies suggest these eyes may have a superior anatomical response to corticosteroids (such as dexamethasone implants) compared to anti-VEGF agents, although a high burden also predicts a shorter duration of treatment efficacy.

Retinal Vein Occlusion (RVO)

In RVO, IHRF are markers of vascular leakage and local inflammation.

• Visual Prognosis: Higher IHRF counts, particularly when associated with disruption of the external limiting membrane (ELM) or ellipsoid zone (EZ), are predictive of poor final visual outcomes.
• Monitoring Inflammation: Like DME, IHRF in RVO decrease following therapy, with dexamethasone implants showing significantly greater effectiveness in reducing IHRF counts than anti-VEGF injections.

Pachychoroid Spectrum and Central Serous Chorioretinopathy (CSCR)

IHRF in CSCR typically represent accumulations of plasma lipoproteins or migrated RPE cells.

• Recurrence and Persistency: A higher baseline number of subretinal and intraretinal IHRF is positively associated with a longer duration of subretinal fluid and an increased rate of recurrence.
• Neovascular Risk: The presence of IHRF in resolved CSCR cases is linked to an increased risk of developing secondary choroidal neovascularization over time.

Inherited Retinal Dystrophies (IRDs)

In IRDs like Stargardt disease, Retinitis Pigmentosa (RP), and Best disease, IHRF mirror the degenerative lifecycle of the retina.

• Disease Staging: In RP, IHRF shift from the inner nuclear layer to the outer nuclear layer as the disease advances, marking the transition from microglial activation to RPE migration into areas of photoreceptor loss.
• Visual Outcomes: Higher central and perifoveal IHRF counts are negatively associated with visual outcomes and signal a faster progression of visual deterioration.

Vitreoretinal Disorders (Epiretinal Membrane)

Within the context of idiopathic epiretinal membranes (iERM), IHRF are viewed as indicators of disease chronicity and mechanical stress.

• Interface Instability: IHRF on the inner retinal surface can predict the onset or progression of iERM following cataract surgery.
• Surgical Prognosis: In advanced stages, IHRF embedded within the ectopic inner foveal layer (EIFL) represent irreversible gliotic remodeling; their persistence after surgery is associated with worse postoperative visual outcomes.